7615 Api for Sale
Compare supplier listings for Api — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
API 99% Apixaban Manufacturer 503612-47-3 Cardiovascular Drugs
-
Price:
Price on request
-
CAS No.:
503612-47-3
CAS 641571-10-0 99% API Nilotinib AMN 107 for Anticancer
-
Price:
Price on request
-
CAS No.:
641571-10-0
Lincomycin Hydrochloride-Pharmaceutical raw material /API
-
Price:
Price on request
-
CAS No.:
859-18-7
Factory Price-Folic acid-Pharmaceutical raw material /API
-
Price:
Price on request
-
CAS No.:
59-30-3
Amoxicillin-Pharmaceutical raw material /API
-
Price:
Price on request
-
CAS No.:
26787-78-0
Products You May Be Interested in
Factory Price-Vitamin C-Pharmaceutical raw material /API
-
Price:
Price on request
-
CAS No.:
50-81-7
bentonite powder-API/1302-78-9/drilling/API grade
-
Price:
Price on request
-
CAS No.:
1302-78-9
cilnidipine api
-
Price:
Price on request
-
CAS No.:
132203-70-4
Animal extract API 1:10000NF,1:15000NF activity pepsin enzyme powder
-
Price:
Price on request
-
CAS No.:
9001-75-6
About Api List
- Buying Api on www.echemi.com where you will find large variety of good choices. Suppliers of 7615 Api registered will be verified by the accurate information. Safe transaction of chemical will be made based on true information. Find your Api order with 70000+ buyers on ECHEMI.
- The quality of Api will be secured by ECHEMI. Our business partners are with certification, quanlification and so on. And we are familiar with the regulatory requirements from different areas of Api. We can offer tailored service of Api for our customers.
- Api in reasonable and fair market price will be provided with better options and services. Services of Api like trade data and market price and insight can be subscribed on ECHEMI. Efficient order options is the key for supply chain services we offer for you. ECHEMI is helping you of Api with global procurement service.
Check Out More Resources
- •Luyin Investment subsidiary Heze Salt introduces Wanhua Chemical as strategic investor with RMB 333 million capital increase
- •Samsung Biologics Launches Formal Bid for PolyPeptide, Reshaping the Global Peptide API CDMO Map
- •BASF Approves €1 Billion Share Buyback Program as Chemical Giant Prioritizes Capital Discipline
- •Ingredion Agrees to Acquire Tate & Lyle for $3.6 Billion, Reshaping the Global Specialty Ingredients Market
- •Middle East Capital Moves In: SABIC Plans RMB 33 Billion Stake in Rongsheng Petrochemical